Skip to menu Skip to content Skip to footer

An Open Label, Multicentre, Phase One Study Incorporating Early Application of CAR T cells for Primary Refractory Aggressive Lymphoma (2019-2026)

Experts

Professor Maher Gandhi

Affiliate of Centre for Extracellular Vesicle Nanomedicine
Centre for Extracellular Vesicle Nanomedicine
Faculty of Health, Medicine and Behavioural Sciences
Honorary Professor
Mater Research Institute-UQ
Faculty of Health, Medicine and Behavioural Sciences
Maher Gandhi
Maher Gandhi

Associate Professor Colm Keane

Principal Research Fellow
Frazer Institute
Faculty of Health, Medicine and Behavioural Sciences
Colm Keane